III Clinic-Biomechanics Laboratory, Rizzoli Orthopaedic Institute, Bologna, Italy.
Am J Sports Med. 2011 Oct;39(10):2153-60. doi: 10.1177/0363546511415658. Epub 2011 Jul 29.
Regenerative techniques, such as autologous chondrocyte implantation (ACI), have emerged as a potential therapeutic option for the treatment of chondral lesions, aiming to recreate a hyaline-like tissue in the damaged articular surface. The clinical application of the regenerative approach is well documented for different types of scaffold but mostly with an evaluation of the clinical outcome at short-term follow-up.
This study was conducted to analyze the clinical outcome obtained with arthroscopic second-generation ACI up to 7 years' follow-up, to assess the durability of the results, and understand its real potential over time.
Case series; Level of evidence, 4.
Sixty-two consecutive patients, 48 men and 14 women with a mean age of 28.1 ± 11.4 years, affected by chondral lesions of the femoral condyles were enrolled and treated with arthroscopic implantation of the bioengineered tissue Hyalograft C. The average size of the defects was 2.5 ± 1.0 cm(2). Patients were evaluated with International Knee Documentation Committee (IKDC), EuroQol visual analog scale (EQ-VAS), and Tegner scores every year for 7 years, and a magnetic resonance imaging evaluation was performed.
A statistically significant improvement was observed in all scores from the basal evaluation to the 84 months' follow-up. The IKDC subjective score increased from 39.6 ± 15.0 to 73.6 ± 18.8 at 12 months; a further slight improvement was observed at 24 months' follow-up (76.5 ± 20.7), and then the results were stable and reached a final 7-year value of 77.3 ± 21.5. Seven cases (11%) failed. A better outcome was obtained in young active men, whereas the worst results were found in degenerative lesions or when previous surgery had been performed. Postoperative magnetic resonance imaging studies in 42 cases revealed a complete filling of the cartilage defect in 57% of the lesions, complete integration of the graft in 62% of cases, intact repair tissue surface in 50%, homogeneous repair tissue structure in 43%, and a graft signal-intensity score that was isointense with the adjacent native cartilage in 43% and 48% of the cases in dual T2-fast spin echo and 3-dimensional gradient echo with fat suppression sequences, respectively.
The analysis of this group of homogeneous patients, prospectively evaluated every year for 7 years, shows that this bioengineered approach with the proper indications may offer good and stable clinical results over time.
再生技术,如自体软骨细胞移植(ACI),已成为治疗软骨损伤的一种潜在治疗选择,旨在在受损的关节表面上再生出透明软骨样组织。不同类型支架的再生方法的临床应用已有大量文献记载,但大多是在短期随访时评估临床结果。
本研究旨在分析关节镜下第二代 ACI 的临床结果,随访时间长达 7 年,评估结果的耐久性,并随着时间的推移了解其真正的潜力。
病例系列;证据水平,4 级。
连续纳入 62 例患者(48 名男性和 14 名女性),平均年龄 28.1±11.4 岁,均患有股骨髁软骨损伤,采用生物工程组织 Hyalograft C 行关节镜下植入治疗。平均缺损大小为 2.5±1.0cm2。患者每年接受国际膝关节文献委员会(IKDC)、欧洲五维健康量表视觉模拟评分(EQ-VAS)和 Tegner 评分评估,随访 7 年,并进行磁共振成像评估。
从基线评估到 84 个月的随访,所有评分均有统计学显著改善。IKDC 主观评分从基线时的 39.6±15.0 分增加到 12 个月时的 73.6±18.8 分;24 个月随访时略有进一步改善(76.5±20.7),随后结果稳定,最终 7 年时达到 77.3±21.5 分。7 例(11%)失败。年轻活跃的男性患者获得更好的结果,而退行性病变或先前手术的患者结果最差。42 例患者的术后磁共振成像研究显示,57%的软骨缺损完全填充,62%的移植物完全整合,50%的修复组织表面完整,43%的修复组织结构均匀,43%和 48%的移植物信号强度评分在双 T2 快速自旋回波和三维梯度回波脂肪抑制序列中与相邻的天然软骨相同。
对这组同质患者进行的前瞻性评估,每年评估一次,随访 7 年,结果表明,在适当适应证下,这种生物工程方法随着时间的推移可能会提供良好且稳定的临床效果。